Q2 Earnings Estimate for TG Therapeutics Issued By B. Riley
TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) – B. Riley boosted their Q2 2025 earnings per share estimates for TG Therapeutics in a report issued on Monday, May 5th. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will post earnings of $0.30 per share for the quarter, up from their prior forecast […]
